Protocol of Assistance to Patients With Covid-19 Submitted to Treatment With HD-tDCS
Coronavirus, COVID-19 Respiratory Infection
About this trial
This is an interventional treatment trial for Coronavirus
Eligibility Criteria
Intensive Care Unit's Inclusion Criteria:
Patients of at least 18 years-old with a PCR-confirmed SARS-CoV-2 diagnosis and receiving mechanical ventilation at least 48 hours of meeting criteria for moderate to severe acute respiratory distress syndrome (ARDS), under weaning, were enrolled in this study. An ARDS diagnosis was made according to the Berlin Definition criteria.
Intensive Care Unit's Exclusion Criteria:
Patients were excluded if they had a condition that could prevent adequate performance of inspiratory muscle training (e.g., neuropathy or myopathy), pregnancy or active lactation, Richmond Agitation and Sedation Scale (RASS) scores between -2 and + 1, Glasgow Coma Scale (GCS) ≤ 8, consent refusal, and contraindications to brain stimulation (e.g., aneurysm clips).
Sites / Locations
- Federal University of Paraíba,Department of PsychologyRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Group 1 - 3.0 mA active HD-tDCS
Group 2 - Sham HD-tDCS
HD-tDCS with 3.0 milliamperes (mA) of intensitive
Sham HD-tDCS